Member Info for driftking27

That's funny the takeover talk re-emerges at a similar point when I bought in 2years ago when Zurich were rumoured to be looking at them.

So the tip was a good sign by The Share Magazine...: - ) Though, is this not breakout based on US government news ?

Here's my bit for other newbie investors looking to take a bite at Biotech sector: http://markets.ft.com/research/Markets/Tearsheets/Business-profile?s=SUN:LSE

I bought after order went through at open, though only a 5% weighting, which I'd say is the average of all my AIM stocks in trading account.

The Share Magazine's rec on a stop loss wasn't 3.8p, but 4.8p. Still undecided on whether to buy big or to buy a position and then top up on a fall? Its just gona have to wait until 16/17th October until I hear about US news.

SREI has been flagged as a top 10 fund/share to invest in, saying anytthing above 8% is too riskt, and either shows lack of growth.

This weeks Share Magazine had this stock mentioned. Shows growth, and is medium risk, and has earning power... They have a stop loss at 0.38p. I need to go away and do some research over weekend.

Heads up, sometimes a buy can mean a sell, and a sell can mean a buy. Keep "...be greedy when people are fearful, and be fearful when people are greedy." Essence of saying, buy when investors / traders are selling, and sell when people are buying. Good luck! These institutional brokers do these ratings to help make MM money, as if the sp held the same price for a longtime, they wouldn't make money. Only BUY, if you believe YOU understand the future consequences of economic changes, like interest rates rising, loosenening & tightening of QE.

With the NAV still around 7.4%, and a dividend of 3.35%, would this be one to invest into with what I have read about Rothschild betting on thee currency markets? Its one I'm now watching and think with my last invetment, I may take a big stab at it next summer when I can get access to money I stoid away in a fixed CASH for 2years. With market capital nearly at £1.96bn, to assets under books of £2.2bn, looks good to me as a buy.

Hi all, How has everyone weighted their holdings in these utility stocks. Mine is NG(7%ish), SSE(6.5ish%), then CNA

Duh, High dividend payers are always dull. What you want is a stock that yields 3.5% same as FTSE for bigger movements. Try PNN, or RIO(lol)... We all have to keep remembering that NG has the highest debt to equity in FTSE100, with around £22bn...( That's scary )

What we can do, is just think about fundamentals and remember oil might not be with us forever, thus renewable energy is at the forefront of energy companies to develop these utilities. I have topped up at end of play, buying another 200 shares, though NG is still my heavyweight at 7.5% of my holding, SSE is 6.5% & CNA at 6%. If brokers have upside of 16%, that's a plus too, though my only concern remains the possible cut in future dividend, but will just buy another a lot on that if it has to happen.

Hey, With the current drop in Utility stocks, and more specifically cNa & SSE, which one would would one hold. I know on full year earnings SSE is cheaper on price/earnings basis, but its cheaper for a good reason due to future earnings. I hold NG, CNA, and SSE, and may consider selling my holding in CNA and use it to top up on SSE, or just leave it well alone. I bought CNA on Mr Buick tipping it 22mths ago at 292p. Though I am NOT buying into SSE coz one believes so due to higher div. Remember higher dividends will underperform in markets that have rising interest rates, and take longer regain sp. That's just my view.

Looks very much Milliband is a brainless twat in regards to his capping on Utility companies! Something I did hint at months ago, and that I can now see the big dividend being reduced as I did mention as well! As foretold!

2nd October to lose 14p...

To help you possibly buy some free shares when the slide does happen, shares don't go up in a straight line, use the 30 day sell and buy rule. http://www.investmentguide.co.uk/sg-tex5.htm

Cheap tobacco Woodford slightly trimmed back his holding of British American Tobacco, but whacked up his stake in Imperial Tobacco (LSE: IMT) (NASDAQOTH: ITYBY.US). The master investor purchased a net 2.55 million of the latter's shares for around £60m at what I calculate to be an average buy price of 2,339p. This is Woodford the contrarian value investor at work, as the earnings and dividend valuations within the table below show. Company Current share price Forward P/E Forward dividend yield Imperial Tobacco 2,132p 9.7 5.8% British American Tobacco 3,255p 14.7 4.4% Cheap pharma Woodford added over a million shares to the High Income fund's stake in AstraZeneca (LSE: AZN) (NYSE: AZN.US) at a net cost of getting on for £33m. My sums say he paid an average of 3,026p a share. As with the tobacco companies, Woodford upped his stake in the lowlier rated of the two FTSE 100 big pharma firms. Company Current share price Forward P/E Forward dividend yield AstraZeneca 3,178p 9.6 5.6% GlaxoSmithKline 1,645p 14.2 4.4% A FTSE 100 financial Woodford, who famously sold out of big financials before they were hammered by the global banking crisis, has invested in a FTSE 100 financial company for the first time since. What a turn up for the books that is! The company in question is insurer Legal & General. Woodford made a relatively small purchase of 2 million shares. Unfortunately, I can't tell you how much he paid, but the average price during the period was 166p and the shares are trading at 187p today. Will Woodford further build his stake in L&G (my guess is yes)? And is he now ready to invest in more FTSE 100 financials (I'm not so sure about that one)? We'll have to wait and see.

Cheap tobacco Woodford slightly trimmed back his holding of British American Tobacco, but whacked up his stake in Imperial Tobacco (LSE: IMT) (NASDAQOTH: ITYBY.US). The master investor purchased a net 2.55 million of the latter's shares for around £60m at what I calculate to be an average buy price of 2,339p. This is Woodford the contrarian value investor at work, as the earnings and dividend valuations within the table below show. Company Current share price Forward P/E Forward dividend yield Imperial Tobacco 2,132p 9.7 5.8% British American Tobacco 3,255p 14.7 4.4% Cheap pharma Woodford added over a million shares to the High Income fund's stake in AstraZeneca (LSE: AZN) (NYSE: AZN.US) at a net cost of getting on for £33m. My sums say he paid an average of 3,026p a share. As with the tobacco companies, Woodford upped his stake in the lowlier rated of the two FTSE 100 big pharma firms. Company Current share price Forward P/E Forward dividend yield AstraZeneca 3,178p 9.6 5.6% GlaxoSmithKline 1,645p 14.2 4.4% A FTSE 100 financial Woodford, who famously sold out of big financials before they were hammered by the global banking crisis, has invested in a FTSE 100 financial company for the first time since. What a turn up for the books that is! The company in question is insurer Legal & General. Woodford made a relatively small purchase of 2 million shares. Unfortunately, I can't tell you how much he paid, but the average price during the period was 166p and the shares are trading at 187p today. Will Woodford further build his stake in L&G (my guess is yes)? And is he now ready to invest in more FTSE 100 financials (I'm not so sure about that one)? We'll have to wait and see.

Hi, I am an investor with both VOD & BT, along with many other FTSE, DOWJ stocks. I believe that KCOM may benefit upside when VOD reach an agreement with VZ. Possibly, investors may put some of their profits in here, as KCOM have a good growth story to that of VOD's that I beliieve Vittorrio will pay too much for future aquisitions, just like the one in 2001! 100p could well be reached by yrs end...?

Hey, This weeks Investors Chronicle has this Investment fund as buy. Shrodders have cut the dividend on the last occassion, but the analysts' advise' this is a one-of. To NAV its trading at a premium of 5%, and that's why they suggest to buy, as it has over the last few mths gone from disc - prem. Pays a div of 5.3%, not 7.75% that LSE states... You will receive 1payment of 0.062p, 0.088p & 0.088p.